Kuhl S, Hollandt J H, Siegert R
HNO-Klinik der Medizinischen Universität zu Lübeck.
Laryngorhinootologie. 1997 Oct;76(10):608-13. doi: 10.1055/s-2007-997488.
nCPAP is a well established method for the management of OSAS. The aim of this study was to evaluate long-term side effects and complications of nCPAP therapy and their influence on the patients compliance with treatment.
Forty-one patients with OSAS were interviewed by questionnaire to elucidate the problems and adverse effects of their nCPAP therapy. The patients were divided into responders and non-responders. Non-responding OSAS patients were using their nCPAP devices less then 5 hours each night by definition.
The number of side effects and type of complication during nCPAP therapy were the same in both the responding and non-responding groups. The most frequently reported problems were a tender region on the bridge of the nose and discomfort associated with a dry nasal mucosa. Although nCPAP treatment was initially accepted by most patients, adverse effects and other difficulties decreased patient compliance, with time, in many cases.
Despite there being no difference between responders and non-responders with respect to the number and severity of complications, it should not be presumed that these side effects do not influence long-term patient compliance with nCPAP therapy. Patients who suffer from symptoms of OSAS tend to accept these adverse effects, while those who do not feel limited by their disease are less persistent in their use of this treatment modality. Identification and elimination of the problems associated with the use of nCPAP equipment may increase longterm patient compliance. Close monitoring in the outpatient department combined with intermittent inpatient assessment in the sleep laboratory will also help to improve acceptance of nCPAP therapy.
无创持续气道正压通气(nCPAP)是治疗阻塞性睡眠呼吸暂停综合征(OSAS)的一种成熟方法。本研究的目的是评估nCPAP治疗的长期副作用和并发症及其对患者治疗依从性的影响。
通过问卷调查的方式对41例OSAS患者进行访谈,以阐明其nCPAP治疗中存在的问题和不良反应。将患者分为反应者和无反应者。根据定义,无反应的OSAS患者每晚使用nCPAP设备的时间少于5小时。
反应组和无反应组在nCPAP治疗期间的副作用数量和并发症类型相同。最常报告的问题是鼻梁处压痛和鼻黏膜干燥相关的不适。尽管大多数患者最初接受了nCPAP治疗,但随着时间的推移,不良反应和其他困难在许多情况下降低了患者的依从性。
尽管反应者和无反应者在并发症的数量和严重程度方面没有差异,但不应假定这些副作用不会影响患者对nCPAP治疗的长期依从性。患有OSAS症状的患者倾向于接受这些不良反应,而那些未感到疾病受限的患者在使用这种治疗方式时则缺乏持久性。识别并消除与使用nCPAP设备相关的问题可能会提高患者长期治疗的依从性。门诊密切监测结合睡眠实验室的间歇性住院评估也将有助于提高对nCPAP治疗的接受度。